Based on limited published evidence, EGFR is a receptor tyrosine kinase belonging to the ERBB family that mediates cell proliferation, differentiation, survival, and division through ligand-induced signaling 1. Beyond canonical EGF signaling, EGFR acts as a hepatitis C virus receptor in hepatocytes, facilitating HCV entry by promoting CD81-CLDN1 receptor complex formation and enhancing membrane fusion [UniProt]. EGFR localizes to multiple cellular compartments including the plasma membrane, focal adhesions, and endosomes, interacting with cadherins and actin filaments. Mutations and dysregulation associate with lung cancer and neonatal nephrocutaneous inflammatory syndrome.